AAAAAA
Results:
1-8
|
Results: 8
Authors:
CORVAISIER S
MAIRE PH
DYVOIRE MYB
BARBAUT X
BLEYZAC N
JELLIFFE RW
Citation: S. Corvaisier et al., COMPARISONS BETWEEN ANTIMICROBIAL PHARMACODYNAMIC INDEXES AND BACTERIAL KILLING AS DESCRIBED BY USING THE ZHI MODEL, Antimicrobial agents and chemotherapy, 42(7), 1998, pp. 1731-1737
Authors:
CORVAISIER S
BLEYZAC N
CONFESSON MA
BUREAU C
MAIRE P
Citation: S. Corvaisier et al., A POPULATION-MODEL FOR AMIKACIN IN NON-IN SULIN-DEPENDENT DIABETIC-PATIENTS USING THE NON PARAMETRIC SOFTWARE NPEM2 (VOL 52, PG 219, 1997), Therapie, 52(5), 1997, pp. 515-515
Authors:
CORVAISIER S
BLEYZAC N
CONFESSON MA
BUREAU C
MAIRE P
Citation: S. Corvaisier et al., A POPULATION-MODEL FOR AMIKACIN IN NON-IN SULIN-DEPENDENT DIABETIC-PATIENTS USING THE NONPARAMETRIC SOFTWARE NPEM2, Therapie, 52(3), 1997, pp. 219-226
Authors:
ALBRAND G
CORVAISIER S
BISSARDON I
BLEYZAC N
MAIRE P
Citation: G. Albrand et al., METABOLIC COMPLICATIONS IN TUBERCULOSIS PATIENTS - THE DISEASE OR THETREATMENT, Journal of the American Geriatrics Society, 45(5), 1997, pp. 658-659
Authors:
BASTIEN O
BOULIEU R
BLEYZAC N
BOISSONNAT P
GARRE JP
DUREAU G
Citation: O. Bastien et al., GANCICLOVIR USE DURING MILD RENAL-FAILURE IN HEART-TRANSPLANTATION, Transplantation proceedings, 28(5), 1996, pp. 2876-2877
Authors:
BLEYZAC N
BOULIEU R
Citation: N. Bleyzac et R. Boulieu, HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF GANCICLOVIR NUCLEOTIDES IN HUMAN MYOCARDIAL TISSUE, Journal of chromatography B. Biomedical applications, 658(1), 1994, pp. 173-176
Authors:
BOULIEU R
BLEYZAC N
Citation: R. Boulieu et N. Bleyzac, STABILITY OF GANCICLOVIR IN BLOOD-SAMPLES, Journal of pharmaceutical and biomedical analysis, 12(9), 1994, pp. 1205-1207
Authors:
BASTIEN O
BOULIEU R
BLEYZAC N
ESTANOVE S
Citation: O. Bastien et al., CLINICAL USE OF GANCICLOVIR DURING RENAL-FAILURE AND CONTINUOUS HEMODIALYSIS, Intensive care medicine, 20(1), 1994, pp. 47-48
Risultati:
1-8
|